Results 61 to 70 of about 15,859 (208)
A Case of Adjuvant Brigatinib in a Patient with ALK-rearranged R0 Resected Oligometastatic Lung Cancer [PDF]
Anaplastic lymphoma kinase (ALK) rearrangement is detected at a low rate in non-small cell lung cancer (NSCLC). Patients with ALK rearrangements have poor responses to conventional cytotoxic chemotherapy.
Nalan Akyürek +4 more
core +1 more source
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
20.500.12530/87854Androgen deprivation therapy (ADT) has been considered for years the standard initial treatment for patients with metastatic prostate cancer (mPC).
Fernando López-Campos +23 more
core +1 more source
ABSTRACT Background Prophylactic pelvic nodal radiotherapy (PRT) aims to eradicate occult pelvic nodal disease in oligometastatic prostate cancer but increases lymphocyte exposure. Its early hematologic safety and lymphocyte recovery when added to radiotherapy to the prostate/prostate region and all imaging‐visible metastases remain uncertain.
Xin Qi +13 more
wiley +1 more source
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Background The aim of this work was to investigate the outcome of metastasis-directed radiotherapy (MDT) in prostate cancer patients with bone metastases following current ESTRO/EORTC subclassifications for oligometastatic disease.
Paul Rogowski +10 more
doaj +1 more source
Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC
Background: Studies have shown that aggressive treatment of non-small cell lung cancer (NSCLC) with oligometastatic disease improves the overall survival (OS) compared to a palliative approach and some immunotherapy checkpoint inhibitors, such as anti ...
Camille Gauvin +11 more
doaj +1 more source
Steering decision making by terminology : oligometastatic versus argometastatic
: Allowing selected patients with few distant metastases to undergo potentially curative local ablation, the designation "oligometastatic" has become a widely popular concept in oncology.
Szturz, P. +5 more
core +1 more source
ABSTRACT Melanoma may present with gastrointestinal metastases decades after primary diagnosis. A man treated for cutaneous melanoma in 1992 had local recurrence in 1993 and an in‐transit metastasis in 2013. Intestinal metastases were resected in 2017. No further recurrence was documented through June 2026.
Per Nyman +4 more
wiley +1 more source
Stereotactic radiotherapy in oligometastatic cancer
Oligometastatic cancer describes a disease state somewhere between localized and metastatic cancer. Proposed definitions of oligometastatic disease have typically used a cut-off of five or fewer sites of disease. Treatment of oligometastatic disease should have the goal of long-term local control, and in selected cases, disease remission. While several
Thomas A C, Kennedy +2 more
openaire +2 more sources
Oligometastatic cancer is characterized by a limited number of metastatic deposits. Compared with lung cancer patients who have more widespread disease, oligometastatic lung cancer patients have more favorable survival outcomes.
David L. Billing, Andreas Rimner
core +1 more source
Non‐small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations often exhibit significant tumor reduction following tyrosine kinase inhibitor (TKI) therapy. Residual tumors frequently remain, however, leading to drug resistance and disease progression.
Fedor Moiseenko +31 more
wiley +1 more source

